Suppr超能文献

聚(ADP-核糖基)化、DNA链断裂、染色质与癌症

Poly(ADP-ribosyl)ation, DNA strand breaks, chromatin and cancer.

作者信息

Boulikas T

机构信息

Linus Pauling Institute of Science and Medicine, Palo Alto, CA.

出版信息

Toxicol Lett. 1993 Apr;67(1-3):129-50. doi: 10.1016/0378-4274(93)90051-x.

Abstract

Studies on poly(ADP-ribosyl)ation related to chromatin structure and to nuclear functions such as repair, gene expression and replication are reviewed. Poly(ADP-ribosyl)ation might be involved in regulating the activity of nuclear enzymes involved in the metabolism of DNA strand breaks such as ligase II and topoisomerases I and II. In addition, it modifies nuclear proteins participating in gene expression including HMG non-histones, large T antigen, acetylated histone H4 and nuclear matrix proteins. It is speculated that poly(ADP-ribose) can induce free DNA domains by removing histones from specific nucleosomes whose DNA has been damaged. This process is proposed to require specific proteins recognizing lesions on DNA that ultimately attach the damaged site on the nuclear matrix where the repair enzymes are located. The role of poly(ADP-ribosyl)ation in carcinogenesis arises from that inhibitors of this modification potentiate the cytotoxicity of DNA-damaging drugs used in cancer chemotherapy and either enhance or inhibit tumor growth.

摘要

本文综述了与染色质结构以及修复、基因表达和复制等核功能相关的聚(ADP - 核糖基)化研究。聚(ADP - 核糖基)化可能参与调节参与DNA链断裂代谢的核酶活性,如连接酶II以及拓扑异构酶I和II。此外,它还修饰参与基因表达的核蛋白,包括HMG非组蛋白、大T抗原、乙酰化组蛋白H4和核基质蛋白。据推测,聚(ADP - 核糖)可通过从特定核小体中去除组蛋白来诱导游离DNA结构域,这些核小体的DNA已受损。该过程被认为需要特定蛋白质识别DNA上的损伤,最终将损伤位点连接到位于核基质上的修复酶所在位置。聚(ADP - 核糖基)化在致癌作用中的作用源于这种修饰的抑制剂会增强用于癌症化疗的DNA损伤药物的细胞毒性,并且要么增强要么抑制肿瘤生长。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验